In a conference organized by the Gordon Center, Dr. Anna Liisa Brownell presented her research group’s efforts to develop novel therapies to Parkinson’s disease. In particular, Dr. Bronwell investigated interplay between dopaminergic and glutamatergic neurotransmission using dopamine-rich fetal cells originating from different species, embryonic stem cells and lately pluripotent stem cells. Dr. Bronwell is currently collaborating with a pharmaceutical company to test an experimental drug in clinical trials. Dr. Brownell is a Professor of Radiology at Harvard Medical School and the Director of the Experimental PET Laboratory at Massachusetts General Hospital.
About the Gordon Center for Medical Imaging:
The Gordon Center for Medical Imaging at Massachusetts General Hospital and Harvard University develops new biomedical imaging technologies used in diagnosis and therapy. In addition to translational research, the Center organizes lectures and symposiums as part of its effort to inspire the public and the scientific community about the latest research topics in medical imaging.